Monroe Capital backs therapeutic products company

The $20 million loan will aid in the growth of the private equity sponsored Cytovance Biologics.

28 October 2014•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.